Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 235
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
End of Phase III Products for the Treatment of Irritable Bowel Syndrome (IBS) Sought
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
The new product sought should act as complimentary product to our corporate pipeline product vedolizumab...
Contact
Participants
You
Email me a copy of this message

The new product sought should act as a complimentary product to our corporate pipeline product vedolizumab.

Type of Business Relationship Sought

No co-funding or co-development expected from Takeda in Nordics

FEATURED
Last Updated Aug 2014
Technology Type
Phase of Development CLINICAL TRIALS
CORPORATION

Opportunity Contact